{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T18:19:15Z","timestamp":1794248355994,"version":"4.9.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T00:00:00Z","timestamp":1693872000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006442","name":"Det Sundhedsvidenskabelige Fakultet, K\u00f8benhavns Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006442","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeck Foundation","doi-asserted-by":"publisher","award":["R186-2015-2138"],"award-info":[{"award-number":["R186-2015-2138"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.ymgme.2023.107694","type":"journal-article","created":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T15:55:59Z","timestamp":1693410959000},"page":"107694","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["X-linked creatine transporter (SLC6A8) deficiency in females: Difficult to recognize, but a potentially treatable disease"],"prefix":"10.1016","volume":"140","author":[{"given":"Malene","family":"Mejdahl Nielsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esben Thade","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina D\u00fchring","family":"Fenger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mette Cathrine","family":"\u00d8rngreen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartwig Roman","family":"Siebner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent Oltman","family":"Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Pova\u017ean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Lund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine Weller","family":"Gr\u00f8nborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trine Bj\u00f8rg","family":"Hammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.ymgme.2023.107694_bb0005","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1021\/acs.biochem.9b00956","article-title":"Classification of the molecular defects associated with pathogenic variants of the SLC6A8 creatine transporter","volume":"59","author":"Salazar","year":"2020","journal-title":"Biochemistry"},{"issue":"6","key":"10.1016\/j.ymgme.2023.107694_bb0010","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1086\/320595","article-title":"X-linked creatine-transporter gene (SLC6A8) defect: a new creatine-deficiency syndrome","volume":"68","author":"Salomons","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2023.107694_bb0015","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1086\/422102","article-title":"High prevalence of SLC6A8 deficiency in X-linked mental retardation","volume":"75","author":"Rosenberg","year":"2004","journal-title":"Am. J. Hum. Genet."},{"issue":"39","key":"10.1016\/j.ymgme.2023.107694_bb0020","first-page":"1","article-title":"Fragile X syndrome: a review of clinical and molecular diagnoses","volume":"43","author":"Ciaccio","year":"2017","journal-title":"Ital. J. Pediatr."},{"key":"10.1016\/j.ymgme.2023.107694_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.biochi.2015.10.022","article-title":"Creatine biosynthesis and transport in health and disease","author":"Joncquel-Chevalier Curt","year":"2015","journal-title":"Biochimie"},{"issue":"1","key":"10.1016\/j.ymgme.2023.107694_bb0030","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ymgme.2021.12.005","article-title":"Current and potential new treatment strategies for creatine deficiency syndromes","volume":"135","author":"Fernandes-Pires","year":"2022","journal-title":"Mol. Genet. Metab."},{"issue":"2","key":"10.1016\/j.ymgme.2023.107694_bb0035","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1471-4159.2010.06935.x","article-title":"Synthesis and transport of creatine in the CNS: importance for cerebral functions","volume":"115","author":"B\u00e9ard","year":"2010","journal-title":"J. Neurochem."},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2023.107694_bb0040","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0169-328X(00)00269-2","article-title":"Endogenous synthesis and transport of creatine in the rat brain: an in situ hybridization study","volume":"86","author":"Braissant","year":"2001","journal-title":"Mol. Brain Res."},{"key":"10.1016\/j.ymgme.2023.107694_bb0045","series-title":"Phenotype and genotype in 101 males with X-linked creatine transporter deficiency","author":"Van De Kamp","year":"2022"},{"issue":"3","key":"10.1016\/j.ymgme.2023.107694_bb0050","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s11011-018-0197-3","article-title":"Treatment outcome of creatine transporter deficiency: international retrospective cohort study","volume":"33","author":"Bruun","year":"2018","journal-title":"Metab. Brain Dis."},{"issue":"2","key":"10.1016\/j.ymgme.2023.107694_bb0055","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/ana.10246","article-title":"X-linked creatine deficiency syndrome: a novel mutation in creatine transporter gene SLC6A8","volume":"52","author":"Bizzi","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymgme.2023.107694_bb0060","series-title":"Estimated carrier frequency of creatine transporter deficiency in females in the general population using functional characterization of novel missense variants in the SLC6A8 gene","author":"Desroches","year":"2015"},{"issue":"1","key":"10.1016\/j.ymgme.2023.107694_bb0065","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1086\/341123","article-title":"Skewed X-chromosome inactivation is a common feature of X-linked mental retardation disorders","volume":"71","author":"Plenge","year":"2002","journal-title":"Am. J. Hum. Genet."},{"issue":"12","key":"10.1016\/j.ymgme.2023.107694_bb0070","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1001\/jama.295.12.1428","article-title":"The role of X inactivation and cellular mosaicism in women\u2019s health and sex-specific diseases","volume":"295","author":"Migeon","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.ymgme.2023.107694_bb0075","article-title":"Laboratory diagnosis of creatine deficiency syndromes: a technical standard and guideline of the American College of Medical Genetics and Genomics","volume":"1","author":"Daniel Sharer","year":"2017","journal-title":"Genet. Med."},{"issue":"1","key":"10.1016\/j.ymgme.2023.107694_bb0080","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s10545-011-9345-1","article-title":"Long-term follow-up and treatment in nine boys with X-linked creatine transporter defect","volume":"35","author":"Van De Kamp","year":"2012","journal-title":"J. Inherit. Metab. Dis."},{"issue":"5","key":"10.1016\/j.ymgme.2023.107694_bb0085","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"issue":"6","key":"10.1016\/j.ymgme.2023.107694_bb0090","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/mrm.1910300604","article-title":"Estimation of metabolite concentrations from localized in vivo proton NMR spectra","volume":"30","author":"Provencher","year":"1993","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.ymgme.2023.107694_bb0095","series-title":"Wechsler Intelligence Scale for Children","author":"Wechsler","year":"2014"},{"key":"10.1016\/j.ymgme.2023.107694_bb0100","first-page":"91","article-title":"A novel SLC6A8 mutation in a large family with X-linked intellectual disability: clinical and proton magnetic resonance spectroscopy data of both hemizygous males and heterozygous females","volume":"13","author":"Dreha-Kulaczewski","year":"2014","journal-title":"JIMD Rep."},{"issue":"1","key":"10.1016\/j.ymgme.2023.107694_bb0105","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1148\/radiol.2020191037","article-title":"Comparison of multivendor single-voxel MR spectroscopy data acquired in healthy brain at 26 sites","volume":"295","author":"Pova\u017ean","year":"2020","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.ymgme.2023.107694_bb0110","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10545-011-9358-9","article-title":"Treatment by oral creatine, L-arginine and L-glycine in six severely affected patients with creatine transporter defect","volume":"35","author":"Valayannopoulos","year":"2012","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2023.107694_bb0115","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.pediatrneurol.2011.10.005","article-title":"Phenotypic variability in a portuguese family with X-linked creatine transport deficiency","volume":"46","author":"Garcia","year":"2012","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.ymgme.2023.107694_bb0120","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1750-1172-7-96","article-title":"Screening for primary creatine deficiencies in French patients with unexplained neurological symptoms equal contributors","volume":"7","author":"Cheillan","year":"2012","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2023.107694_bb0125","series-title":"Variable White Matter Atrophy and Intellectual Development in a Family With X-linked Creatine Transporter Deficiency Despite Genotypic Homogeneity","author":"Heussinger","year":"2021"},{"issue":"4","key":"10.1016\/j.ymgme.2023.107694_bb0130","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.radcr.2022.01.053","article-title":"Case report: Clinical and magnetic resonance spectroscopy presentation of a female severely affected with X-linked creatine transporter deficiency","volume":"17","author":"Morey","year":"2022","journal-title":"Radiol. Case Rep."},{"issue":"5","key":"10.1016\/j.ymgme.2023.107694_bb0135","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1086\/340092","article-title":"X-linked mental retardation with seizures and carrier manifestations is caused by a mutation in the creatine-transporter gene (SLC6A8) located in Xq28","volume":"70","author":"Hahn","year":"2002","journal-title":"Am. J. Hum. Genet."},{"issue":"5","key":"10.1016\/j.ymgme.2023.107694_bb0140","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1055\/s-2002-36743","article-title":"Congenital creatine transporter deficiency","volume":"33","author":"DeGrauw","year":"2002","journal-title":"Neuropediatrics"},{"issue":"1","key":"10.1016\/j.ymgme.2023.107694_bb0145","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/00004728-200301000-00009","article-title":"Magnetic resonance spectroscopy in a 9-day-old heterozygous female child with creatine transporter deficiency","volume":"27","author":"Cecil","year":"2003","journal-title":"J. Comput. Assist. Tomogr."},{"key":"10.1016\/j.ymgme.2023.107694_bb0150","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1023\/A:1022487218904","article-title":"The clinical syndrome of creatine transporter deficiency","volume":"244","author":"DeGrauw","year":"2003","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.ymgme.2023.107694_bb0155","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s10334-008-0137-z","article-title":"H MR spectroscopy as a diagnostic tool for cerebral creatine deficiency","volume":"21","author":"Dezortova","year":"2008","journal-title":"Magn. Reson. Mater. Phy."},{"issue":"3","key":"10.1016\/j.ymgme.2023.107694_bb0160","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1399-0004.2010.01460.x","article-title":"Clinical features and X-inactivation in females heterozygous for creatine transporter defect","volume":"79","author":"Van De Kamp","year":"2011","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ymgme.2023.107694_bb0165","series-title":"Treatment of Intractable Epilepsy in a Female with SLC6A8 Deficiency","author":"Mercimek-Mahmutoglu","year":"2010"},{"issue":"6","key":"10.1016\/j.ymgme.2023.107694_bb0170","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1111\/j.1528-1167.2007.01148.x","article-title":"Severe epilepsy in X-linked creatine transporter defect (CRTR-D)","volume":"48","author":"Margherita Mancardi","year":"2007","journal-title":"Epilepsia."},{"issue":"9","key":"10.1016\/j.ymgme.2023.107694_bb0175","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/gim.2017.1","article-title":"A clinical utility study of exome sequencing versus conventional genetic testing in pediatric neurology","volume":"19","author":"Vissers","year":"2017","journal-title":"Genet. Med."},{"issue":"43","key":"10.1016\/j.ymgme.2023.107694_bb0180","first-page":"1","article-title":"Neuropsychological profile and clinical effects of arginine treatment in children with creatine transport deficiency","volume":"7","author":"Chilosi","year":"2012","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2023.107694_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bcr-2020-237542","article-title":"Creatine transporter deficiency, an underdiagnosed cause of male intellectual disability","volume":"13","author":"Jangid","year":"2020","journal-title":"BMJ Case Rep."},{"issue":"4","key":"10.1016\/j.ymgme.2023.107694_bb0190","doi-asserted-by":"crossref","DOI":"10.1002\/mgg3.1640","article-title":"Treatment efficacy of high-dose creatine supplementation in a child with creatine transporter (SLC6A8) deficiency","volume":"9","author":"Shi","year":"2021","journal-title":"Mol. Genet. Genomic Med."},{"issue":"4","key":"10.1016\/j.ymgme.2023.107694_bb0195","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ymgme.2014.05.011","article-title":"Stockler-Ipsiroglu S, van Karnebeek CDM. Treatment of X-linked creatine transporter (SLC6A8) deficiency: systematic review of the literature and three new cases","volume":"112","author":"Dunbar","year":"2014","journal-title":"Mol. Genet. Metab."},{"issue":"3","key":"10.1016\/j.ymgme.2023.107694_bb0200","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1152\/physrev.2000.80.3.1107","article-title":"Creatine and creatinine metabolism","volume":"80","author":"Wyss","year":"2000","journal-title":"Physiol. Rev."},{"issue":"suppl I","key":"10.1016\/j.ymgme.2023.107694_bb0205","first-page":"I-16","article-title":"Myocardial expression of the arginine:glycine amidinotransferase gene is elevated in heart failure and normalized after recovery","volume":"114","author":"Cullen","year":"2006","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.ymgme.2023.107694_bb0210","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/hmg\/ddh112","article-title":"Severely altered guanidino compound levels, disturbed body weight homeostasis and impaired fertility in a mouse model of guanidinoacetate N-methyltransferase (GAMT) deficiency","volume":"13","author":"Schmidt","year":"2004","journal-title":"Hum. Mol. Genet."},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2023.107694_bb0215","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1023\/B:MCBI.0000038213.15646.4a","article-title":"Presence of normal creatine in the muscle of a patient with a mutation in the creatine transporter: a case study","volume":"262","author":"Pyne-Geithman","year":"2004","journal-title":"Mol. Cell. Biochem."},{"issue":"4","key":"10.1016\/j.ymgme.2023.107694_bb0220","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.neuroscience.2006.06.058","article-title":"The creatine transporter mediates the uptake of creatine by brain tissue, but not the uptake of two creatine-derived compounds","volume":"142","author":"Lunardi","year":"2006","journal-title":"Neuroscience."},{"issue":"1","key":"10.1016\/j.ymgme.2023.107694_bb0225","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-75436-4","article-title":"Cyclocreatine treatment ameliorates the cognitive, autistic and epileptic phenotype in a mouse model of Creatine transporter deficiency","volume":"10","author":"Cacciante","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymgme.2023.107694_bb0230","series-title":"Response to Creatine Analogs in Fibroblasts and Patients with Creatine Transporter Deficiency","author":"Fons","year":"2009"},{"issue":"12","key":"10.1016\/j.ymgme.2023.107694_bb0235","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.2217\/nnm-2019-0059","article-title":"Dodecyl creatine ester-loaded nanoemulsion as a promising therapy for creatine transporter deficiency","author":"Ullio-Gamboa","year":"2019","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ymgme.2023.107694_bb0240","series-title":"Rescue by 4-phenylbutyrate of several misfolded creatine transporter-1 variants linked to the creatine transporter deficiency syndrome","author":"El-Kasaby","year":"2019"},{"issue":"10","key":"10.1016\/j.ymgme.2023.107694_bb0245","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1177\/1060028020914274","article-title":"Onasemnogene Abeparvovec-xioi: gene therapy for spinal muscular atrophy","volume":"54","author":"Stevens","year":"2020","journal-title":"Ann. Pharmacother."},{"issue":"18","key":"10.1016\/j.ymgme.2023.107694_bb0250","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa1702752","article-title":"Nusinersen versus sham control in infantile-onset spinal muscular atrophy","volume":"377","author":"Finkel","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.ymgme.2023.107694_bb0255","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12072532","article-title":"Epilepsy in Dravet syndrome-current and future therapeutic opportunities","volume":"12","author":"Gao","year":"2023","journal-title":"J. Clin. Med."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719223003244?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719223003244?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T17:14:42Z","timestamp":1735233282000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719223003244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S1096719223003244"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2023.107694","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"X-linked creatine transporter (SLC6A8) deficiency in females: Difficult to recognize, but a potentially treatable disease","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2023.107694","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107694"}}